Company / Current Liabilities per Share
Zenas BioPharma, Inc. Current Liabilities per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.50
FY2025
5-year range
$1.50 / $36.33
FY2023-FY2025
Trend
-95.9%
vs FY2024
Sector context
#88 of 210
Health Care
What the data says
At $1.50, Zenas BioPharma, Inc.'s current liabilities per share ranks #123 of 210 in the Health Care sector. Improved from $15.19 to $1.50 over the past 2 years.
Based on SEC 10-K filings.
1.50 in FY2025.
Improved from $15.19 to $1.50 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#123 of 210 in Health CareTop 58% of 210This company $1.50 Sector average $23.79
▼
-93.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 95.9% year-over-year.
- Ranks #88 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.50 | -95.9% |
| FY2024 | $36.33 | +139.2% |
| FY2023 | $15.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026